| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print January 17, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00597.2001
Submitted on July 20, 2001
Accepted on January 9, 2002
1 Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA
2 Beohringer Ingelheim Pharmaceutical, Ridgefield, CT, USA
3 Biochemistry, Univ Texas Southwestern Medical Center, Dallas, TX, USA
* To whom correspondence should be addressed. E-mail: wbcamp{at}mcw.edu.
Epoxyeicosatrienoic acids (EETs) cause vascular relaxation by activating smooth muscle large-conductance, calcium-activated potassium (KCa) channels. EETs are metabolized to dihydroxyeicosatrienoic acids (DHETs) by epoxide hydrolase. We examined the contribution of 14,15-DHET to 14,15-EET-induced relaxations and characterized its mechanism of action. 14,15-DHET relaxed U-46619-precontracted bovine coronary artery rings but was approximately 5-fold less potent than 14,15-EET. The relaxations were inhibited by charybdotoxin, iberiotoxin and increasing extracellular K to 20 mM. In isolated smooth muscle cells, 14,15-DHET increased an iberiotoxin-sensitive, outward K current and increased KCa channel activity in cell-attached patches and inside out patches only when GTP is present. 14C-14,15-EET-methyl ester (Me) was converted to 14C -14,15-DHET-Me, -14,15-DHET and -14,15-EET by coronary arterial rings and endothelial cells but not smooth muscle cells. The metabolism to 14,15-DHET was inhibited by the epoxide hydrolase inhibitors, 4-phenylchalcone oxide (4-PCO) and BIRD-0826. Neither inhibitor altered relaxations to acetylcholine, whereas relaxations to 14,15-EET-Me were increased slightly by BIRD-0826 but not by 4-PCO. 14,15-DHET relaxes coronary arteries through activation of KCa channels. Endothelial cells, but not smooth muscle cells convert EETs to DHETs, and this conversion results in a loss of vasodilator activity.
This article has been cited by other articles:
|
|
 |
|
  Y. Chawengsub, K. M. Gauthier, and W. B. Campbell Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H495 - H507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Hercule, W.-H. Schunck, V. Gross, J. Seringer, F. P. Leung, S. M. Weldon, A. Ch. da Costa Goncalves, Y. Huang, F. C. Luft, and M. Gollasch Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Nayeem, S. M. Poloyac, J. R. Falck, D. C. Zeldin, C. Ledent, D. S. Ponnoth, H. R. Ansari, and S. J. Mustafa Role of CYP epoxygenases in A2AAR-mediated relaxation using A2AAR-null and wild-type mice Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2068 - H2078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Yi, K. M. Gauthier, L. Cui, K. Nithipatikom, J. R. Falck, and W. B. Campbell Metabolism of adrenic acid to vasodilatory 1{alpha},1beta-dihomo-epoxyeicosatrienoic acids by bovine coronary arteries Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2265 - H2274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, T. Tazzeo, V. Chu, and L. J. Janssen Membrane potassium currents in human radial artery and their regulation by nitric oxide donor Cardiovasc Res, July 15, 2006; 71(2): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha} Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Campbell, B. B. Holmes, J. R. Falck, J. H. Capdevila, and K. M. Gauthier Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H64 - H71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vriens, G. Owsianik, B. Fisslthaler, M. Suzuki, A. Janssens, T. Voets, C. Morisseau, B.D. Hammock, I. Fleming, R. Busse, et al. Modulation of the Ca2 Permeable Cation Channel TRPV4 by Cytochrome P450 Epoxygenases in Vascular Endothelium Circ. Res., October 28, 2005; 97(9): 908 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Falck, U. M. Krishna, Y. K. Reddy, P. S. Kumar, K. M. Reddy, S. B. Hittner, C. Deeter, K. K. Sharma, K. M. Gauthier, and W. B. Campbell Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H337 - H349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M Gauthier, C. Liu, A. Popovic, S. Albarwani, and N. J Rusch Freshly isolated bovine coronary endothelial cells do not express the BKCa channel gene J. Physiol., December 15, 2002; 545(3): 829 - 836. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
